Cat No.
CEI-0392
Description
LY2886721 is an oral, small molecule of beta-site amyloid protein cleaving enzyme (BACE) inhibitor with the potential to inhibit the synthesis of beta-amyloid and thereby to slow the clinical progression of AD.
CAS No.
1262036-50-9
Targets
BACE
M.Wt
390.41
Purity
>99%
Solubility
DMSO 9 mg/mL,Water
Storage
2 years at -20 centigrade